Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.

Raghav, Pawan Kumar; Mann, Zoya; Ahluwalia, Simran Kaur; Rajalingam, Raja

Raghav, Pawan Kumar; Mann, Zoya; Ahluwalia, Simran Kaur; Rajalingam, Raja.

Afiliação

Raghav PK; Immunogenetics and Transplantation Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA. Electronic address: PwnRghv@gmail.com.
Mann Z; BioExIn, Delhi, India.
Ahluwalia SK; Amity Institute of Biotechnology, Amity University, Sector-125, Noida, Uttar Pradesh, India.
Rajalingam R; Immunogenetics and Transplantation Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.

J Pharmacol Sci ; 152(1): 1-21, 2023 May.

Article em En | MEDLINE | ID: mdl-37059487

Assuntos

COVID-19; Humanos; SARS-CoV-2/metabolismo; Reposicionamento de Medicamentos; Tratamento Farmacológico da COVID-19; Peptidil Dipeptidase A/genética; Peptidil Dipeptidase A/metabolismo; Ligação Proteica

Palavras-chave

COVID-19; Clinical trials; Drug repurposing; SARS-CoV-2; Vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google